Assessing the Glycemic Impact of an Online Lifestyle Intervention Using CGM (Continuous Glucose Monitoring). a Pilot Study.
试验速览
- 阶段
- 不适用
- 状态
- Enrolling By Invitation
- 发起方
- 入组人数
- 100
- 试验地点
- 1
- 主要终点
- Glycemic Control (Time-in-Range)
研究概览
简要总结
The primary objective of this study is to determine the impact of participating in an online lifestyle intervention program on glycemic control as measured by Continuous Glucose Monitoring (CGM), with the primary outcome being the time-in-range (TIR) between 70 and 140 mg/dl comparing before the intervention, at the start of the program (week 1), and after the intervention (week 8).
详细描述
The Metabolic Wellness Program (MWP) is an established 8-week program that provides participants with digitally delivered health education focusing on metabolic health. The program content is based on nutrition education, promotion of physical activity, stress reduction and the need for quality sleep. The MWP also includes the use of continuous glucose monitoring (CGM), The MWP is aimed at adults with pre-existing type 2 diabetes (T2D), prediabetes and also individuals who wish to retain their metabolic health. (More information about the program is available here: https://www.sutterhealth.org/classes-events/the-metabolic-wellness-program-34466
To evaluate the success (or otherwise) of the MWP, the aim of this pilot study is to assess the impact of participating in the MWP on glycemic control, with the primary outcome being the time-in-range between 70 and 140 mg/dl measured by CGM. Data from this pilot study will provide evidence for a larger future randomized controlled trial (RCTs).
The secondary objectives are to:
- Examine additional changes in CGM variables comparing before (at baseline)and after the intervention (at week 8 and at 3 months post-intervention) Examine changes in self-reported behavior changes related to food choices, physical activity, sleep quality, and stress levels.
- Examine changes in lab values (if available as part of routine clinical care from the previous 12 months and up to 6 months after the program): and
- Examine engagement with the program, engagement with CGM, and satisfaction with the program
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Adults who are enrolled in the MWP
- •Adults ≥ 18 years of age at enrollment.
- •Willing to wear a CGM device.
- •Sutter Health employee or employee's dependent enrolled in SutterSelect Employee Medical Benefits
排除标准
- •Pregnancy
- •Taking insulin
- •Chronic kidney disease and on dialysis
- •Any active clinically significant disease or disorder which, in the investigator's opinion, could interfere with participation in the study
结局指标
主要结局
Glycemic Control (Time-in-Range)
时间窗: Baseline and Weeks 2, 7-8
Time-in-range (TIR) between 70 and 140 mg/dl as measured by CGM.
次要结局
未报告次要终点
研究者
David Kerr
Senior Investigator, Diabetes and Digital Health Equity
Palo Alto Medical Foundation
